TreeWAS – Variant ID: rs7112513

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
E78.0 Pure hypercholesterolaemia	0.000	0.023	0.977
E78 Disorders of lipoprotein metabolism and other lipidaemias	0.000	0.516	0.484
E78.2 Mixed hyperlipidaemia	0.000	0.556	0.444
E78.5 Hyperlipidaemia, unspecified	0.000	0.613	0.387
E78.1 Pure hyperglyceridaemia	0.000	0.643	0.357
E78.3 Hyperchylomicronaemia	0.000	0.667	0.333
E78.6 Lipoprotein deficiency	0.000	0.667	0.332
E78.9 Disorder of lipoprotein metabolism, unspecified	0.000	0.689	0.311
E78.4 Other hyperlipidaemia	0.000	0.728	0.271
E78.8 Other disorders of lipoprotein metabolism	0.000	0.732	0.267
H26.9 Cataract, unspecified	0.000	0.953	0.047
H26 Other cataract	0.000	0.972	0.028
J69.0 Pneumonitis due to food and vomit	0.026	0.974	0.000
H26.0 Infantile, juvenile and presenile cataract	0.000	0.977	0.023
H26.3 Drug-induced cataract	0.000	0.978	0.022
J69 Pneumonitis due to solids and liquids	0.020	0.980	0.000
H26.8 Other specified cataract	0.000	0.980	0.020
H26.2 Complicated cataract	0.000	0.980	0.020
J61 Pneumoconiosis due to asbestos and other mineral fibres	0.018	0.982	0.000
H25.1 Senile nuclear cataract	0.000	0.982	0.018
I34.0 Mitral (valve) insufficiency	0.000	0.982	0.018
H25-H28 Disorders of lens	0.000	0.982	0.018
J60-J70 Lung diseases due to external agents	0.018	0.982	0.000
H26.1 Traumatic cataract	0.000	0.983	0.016
H26.4 After-cataract	0.000	0.984	0.016
O68.1 Labour and delivery complicated by meconium in amniotic fluid	0.016	0.984	0.000
H25 Senile cataract	0.000	0.985	0.015
J69.1 Pneumonitis due to oils and essences	0.015	0.985	0.000
M16.1 Other primary coxarthrosis	0.015	0.985	0.000
M16 Coxarthrosis [arthrosis of hip]	0.014	0.986	0.000
H27 Other disorders of lens	0.000	0.986	0.014
J64 Unspecified pneumoconiosis	0.014	0.986	0.000
I34 Nonrheumatic mitral valve disorders	0.000	0.986	0.014
I10 Essential (primary) hypertension	0.000	0.986	0.014
M16.9 Coxarthrosis, unspecified	0.014	0.986	0.000
J60 Coalworker's pneumoconiosis	0.013	0.987	0.000
J69.8 Pneumonitis due to other solids and liquids	0.013	0.987	0.000
J70 Respiratory conditions due to other external agents	0.013	0.987	0.000
M16.0 Primary coxarthrosis, bilateral	0.013	0.987	0.000
J68 Respiratory conditions due to inhalation of chemicals, gases, fumes and vapours	0.013	0.987	0.000
J66 Airway disease due to specific organic dust	0.013	0.987	0.000
J63 Pneumoconiosis due to other inorganic dusts	0.013	0.987	0.000
J65 Pneumoconiosis associated with tuberculosis	0.013	0.987	0.000
H28 Cataract and other disorders of lens in diseases classified elsewhere	0.000	0.987	0.013
I34.1 Mitral (valve) prolapse	0.000	0.987	0.013
Z08.7 Follow-up examination after combined treatment for malignant neoplasm	0.000	0.987	0.013
J62 Pneumoconiosis due to dust containing silica	0.012	0.988	0.000
H25.2 Senile cataract, morgagnian type	0.000	0.988	0.012
H27.1 Dislocation of lens	0.000	0.988	0.012
I34.8 Other nonrheumatic mitral valve disorders	0.000	0.988	0.012
J67 Hypersensitivity pneumonitis due to organic dust	0.012	0.988	0.000
M16.7 Other secondary coxarthrosis	0.012	0.988	0.000
I34.2 Nonrheumatic mitral (valve) stenosis	0.000	0.989	0.011
M16.5 Other posttraumatic coxarthrosis	0.011	0.989	0.000
M16.2 Coxarthrosis resulting from dysplasia, bilateral	0.010	0.990	0.000
M16.4 Posttraumatic coxarthrosis, bilateral	0.010	0.990	0.000
H27.9 Disorder of lens, unspecified	0.000	0.990	0.010
H27.8 Other specified disorders of lens	0.000	0.990	0.010
M16.6 Other secondary coxarthrosis, bilateral	0.010	0.990	0.000
J70.1 Chronic and other pulmonary manifestations due to radiation	0.010	0.990	0.000
J70.9 Respiratory conditions due to unspecified external agent	0.009	0.990	0.000
J70.8 Respiratory conditions due to other specified external agents	0.009	0.990	0.000
J70.3 Chronic drug-induced interstitial lung disorders	0.009	0.990	0.000
J70.2 Acute drug-induced interstitial lung disorders	0.009	0.990	0.000
J63.8 Pneumoconiosis due to other specified inorganic dusts	0.009	0.990	0.000
J63.5 Stannosis	0.009	0.990	0.000
J63.4 Siderosis	0.009	0.990	0.000
J63.3 Graphite fibrosis (of lung)	0.009	0.990	0.000
J63.2 Berylliosis	0.009	0.990	0.000
J63.1 Bauxite fibrosis (of lung)	0.009	0.990	0.000
J63.0 Aluminosis (of lung)	0.009	0.990	0.000
J66.8 Airway disease due to other specific organic dusts	0.009	0.990	0.000
J66.2 Cannabinosis	0.009	0.990	0.000
J66.1 Flax-dresser's disease	0.009	0.990	0.000
J66.0 Byssinosis	0.009	0.990	0.000
J68.9 Unspecified respiratory condition due to chemicals, gases, fumes and vapours	0.009	0.990	0.000
J68.8 Other respiratory conditions due to chemicals, gases, fumes and vapours	0.009	0.990	0.000
J68.4 Chronic respiratory conditions due to chemicals, gases, fumes and vapours	0.009	0.990	0.000
J68.3 Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vapours	0.009	0.990	0.000
J68.2 Upper respiratory inflammation due to chemicals, gases, fumes and vapours, not elsewhere classified	0.009	0.990	0.000
J68.1 Acute pulmonary oedema due to chemicals, gases, fumes and vapours	0.009	0.990	0.000
J68.0 Bronchitis and pneumonitis due to chemicals, gases, fumes and vapours	0.009	0.990	0.000
H28.8 Other disorders of lens in diseases classified elsewhere	0.000	0.990	0.009
H28.2 Cataract in other diseases classified elsewhere	0.000	0.990	0.009
H28.1 Cataract in other endocrine, nutritional and metabolic diseases	0.000	0.990	0.009
J70.0 Acute pulmonary manifestations due to radiation	0.009	0.990	0.000
J70.4 Drug-induced interstitial lung disorder, unspecified	0.009	0.991	0.000
M16.3 Other dysplastic coxarthrosis	0.009	0.991	0.000
H28.0 Diabetic cataract	0.000	0.991	0.009
J62.0 Pneumoconiosis due to talc dust	0.009	0.991	0.000
H25.0 Senile incipient cataract	0.000	0.991	0.009
I34.9 Nonrheumatic mitral valve disorder, unspecified	0.000	0.991	0.009
J67.2 Bird fancier's lung	0.009	0.991	0.000
Z08 Follow-up examination after treatment for malignant neoplasm	0.000	0.991	0.009
J67.8 Hypersensitivity pneumonitis due to other organic dusts	0.009	0.991	0.000
J67.7 Air-conditioner and humidifier lung	0.009	0.991	0.000
J67.6 Maple-bark-stripper's lung	0.009	0.991	0.000
J67.5 Mushroom-worker's lung	0.009	0.991	0.000
J67.4 Maltworker's lung	0.009	0.991	0.000
J67.3 Suberosis	0.009	0.991	0.000
J67.1 Bagassosis	0.009	0.991	0.000
J67.0 Farmer's lung	0.009	0.991	0.000
J62.8 Pneumoconiosis due to other dust containing silica	0.008	0.991	0.000
Z08.0 Follow-up examination after surgery for malignant neoplasm	0.000	0.991	0.009
H27.0 Aphakia	0.000	0.991	0.008
H25.9 Senile cataract, unspecified	0.000	0.992	0.008
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm	0.000	0.992	0.008
H02.9 Disorder of eyelid, unspecified	0.000	0.992	0.008
J67.9 Hypersensitivity pneumonitis due to unspecified organic dust	0.007	0.993	0.000
O68 Labour and delivery complicated by foetal stress [distress]	0.007	0.993	0.000
S92.00 Fracture of calcaneus (closed)	0.000	0.993	0.007
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid	0.007	0.993	0.000
Z08.1 Follow-up examination after radiotherapy for malignant neoplasm	0.000	0.993	0.007
R29.6 Tendency to fall, not elsewhere classified	0.007	0.993	0.000
Z08.8 Follow-up examination after other treatment for malignant neoplasm	0.000	0.993	0.007
N94.8 Other specified conditions associated with female genital organs and menstrual cycle	0.000	0.993	0.007
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.006	0.993	0.000
Z45.8 Adjustment and management of other implanted devices	0.000	0.994	0.006
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.000	0.994	0.006
I74 Arterial embolism and thrombosis	0.000	0.994	0.006
I74.0 Embolism and thrombosis of abdominal aorta	0.000	0.995	0.005
C45.0 Mesothelioma of pleura	0.005	0.995	0.000
G93.3 Postviral fatigue syndrome	0.000	0.995	0.005
I71 Aortic aneurysm and dissection	0.000	0.995	0.005
I74.5 Embolism and thrombosis of iliac artery	0.000	0.995	0.005
I74.8 Embolism and thrombosis of other arteries	0.000	0.995	0.005
D05.9 Carcinoma in situ of breast, unspecified	0.000	0.995	0.005
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.005	0.995	0.000
C45 Mesothelioma	0.005	0.995	0.000
H02.1 Ectropion of eyelid	0.000	0.995	0.005
I71.9 Aortic aneurysm of unspecified site, without mention of rupture	0.000	0.995	0.005
I71.4 Abdominal aortic aneurysm, without mention of rupture	0.000	0.995	0.005
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.000	0.995	0.005
C45.9 Mesothelioma, unspecified	0.005	0.995	0.000
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm	0.000	0.995	0.005
O68.3 Labour and delivery complicated by biochemical evidence of foetal stress	0.004	0.995	0.000
C45.7 Mesothelioma of other sites	0.005	0.995	0.000
I74.9 Embolism and thrombosis of unspecified artery	0.000	0.995	0.004
I71.6 Thoracoabdominal aortic aneurysm, without mention of rupture	0.000	0.995	0.004
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.000	0.995	0.004
I74.1 Embolism and thrombosis of other and unspecified parts of aorta	0.000	0.995	0.004
I71.2 Thoracic aortic aneurysm, without mention of rupture	0.000	0.996	0.004
D05.0 Lobular carcinoma in situ	0.000	0.996	0.004
S92.0 Fracture of calcaneus	0.000	0.996	0.004
I27.0 Primary pulmonary hypertension	0.004	0.996	0.000
N48.6 Balanitis xerotica obliterans	0.000	0.996	0.004
S32.50 Fracture of pubis (closed)	0.000	0.996	0.004
T81.3 Disruption of operation wound, not elsewhere classified	0.004	0.996	0.000
D05 Carcinoma in situ of breast	0.000	0.996	0.004
R25.2 Cramp and spasm	0.000	0.996	0.004
I70-I79 Diseases of arteries, arterioles and capillaries	0.000	0.996	0.004
I71.8 Aortic aneurysm of unspecified site, ruptured	0.000	0.996	0.004
I71.5 Thoracoabdominal aortic aneurysm, ruptured	0.000	0.996	0.004
I71.0 Dissection of aorta [any part]	0.000	0.996	0.004
C45.2 Mesothelioma of pericardium	0.004	0.996	0.000
R29 Other symptoms and signs involving the nervous and musculoskeletal systems	0.004	0.996	0.000
E21.0 Primary hyperparathyroidism	0.000	0.996	0.004
S27.20 Traumatic haemopneumothorax (without open wound into thoracic cavity)	0.000	0.996	0.004
I71.1 Thoracic aortic aneurysm, ruptured	0.000	0.996	0.004
I71.3 Abdominal aortic aneurysm, ruptured	0.000	0.996	0.004
M51.2 Other specified intervertebral disk displacement	0.004	0.996	0.000
H02 Other disorders of eyelid	0.000	0.996	0.004
S92.01 Fracture of calcaneus (open)	0.000	0.996	0.003
C45.1 Mesothelioma of peritoneum	0.003	0.996	0.000
H02.0 Entropion and trichiasis of eyelid	0.000	0.996	0.004
D05.7 Other carcinoma in situ of breast	0.000	0.996	0.003
I70 Atherosclerosis	0.000	0.997	0.003
I78 Diseases of capillaries	0.000	0.997	0.003
G30.9 Alzheimer's disease, unspecified	0.003	0.997	0.000
I78.0 Hereditary haemorrhagic telangiectasia	0.000	0.997	0.003
D03 Melanoma in situ	0.000	0.997	0.003
I72 Other aneurysm	0.000	0.997	0.003
D03.4 Melanoma in situ of scalp and neck	0.000	0.997	0.003
R29.8 Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems	0.003	0.997	0.000
G31.9 Degenerative disease of nervous system, unspecified	0.003	0.997	0.000
T78.2 Anaphylactic shock, unspecified	0.003	0.997	0.000
R29.1 Meningismus	0.003	0.997	0.000
G30 Alzheimer's disease	0.003	0.997	0.000
D03.5 Melanoma in situ of trunk	0.000	0.997	0.003
I72.8 Aneurysm of other specified arteries	0.000	0.997	0.003
I70.2 Atherosclerosis of arteries of the extremities	0.000	0.997	0.003
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.003	0.997	0.000
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.000	0.997	0.003
R29.4 Clicking hip	0.003	0.997	0.000
R29.3 Abnormal posture	0.003	0.997	0.000
D03.6 Melanoma in situ of upper limb, including shoulder	0.000	0.997	0.003
R29.0 Tetany	0.003	0.997	0.000
N99.3 Prolapse of vaginal vault after hysterectomy	0.003	0.997	0.000
H02.5 Other disorders affecting eyelid function	0.000	0.997	0.003
H02.7 Other degenerative disorders of eyelid and periocular area	0.000	0.997	0.003
G31 Other degenerative diseases of nervous system, not elsewhere classified	0.003	0.997	0.000
E70-E90 Metabolic disorders	0.000	0.997	0.003
R29.2 Abnormal reflex	0.003	0.997	0.000
H02.3 Blepharochalasis	0.000	0.997	0.003
I70.8 Atherosclerosis of other arteries	0.000	0.997	0.003
D03.0 Melanoma in situ of lip	0.000	0.997	0.003
H02.2 Lagophthalmos	0.000	0.997	0.003
I70.0 Atherosclerosis of aorta	0.000	0.997	0.003
Q23.1 Congenital insufficiency of aortic valve	0.003	0.997	0.000
D03.3 Melanoma in situ of other and unspecified parts of face	0.000	0.997	0.003
I78.8 Other diseases of capillaries	0.000	0.997	0.003
S32.5 Fracture of pubis	0.000	0.997	0.003
C49 Malignant neoplasm of other connective and soft tissue	0.003	0.997	0.000
T78.3 Angioneurotic oedema	0.003	0.997	0.000
I72.0 Aneurysm of carotid artery	0.000	0.997	0.003
I72.1 Aneurysm of artery of upper extremity	0.000	0.997	0.003
I78.9 Disease of capillaries, unspecified	0.000	0.997	0.003
I70.9 Generalised and unspecified atherosclerosis	0.000	0.997	0.003
D03.8 Melanoma in situ of other sites	0.000	0.997	0.003
G30.0 Alzheimer's disease with early onset	0.003	0.997	0.000
I70.1 Atherosclerosis of renal artery	0.000	0.997	0.003
Y45.0 Opioids and related analgesics	0.003	0.997	0.000
G31.8 Other specified degenerative diseases of nervous system	0.003	0.997	0.000
I72.5 Aneurysm and dissection of other precerebral arteries	0.000	0.997	0.003
E75 Disorders of sphingolipid metabolism and other lipid storage disorders	0.000	0.997	0.003
D03.2 Melanoma in situ of ear and external auricular canal	0.000	0.997	0.003
G30.1 Alzheimer's disease with late onset	0.003	0.997	0.000
T93.3 Sequelae of dislocation, sprain and strain of lower limb	0.000	0.997	0.003
T78 Adverse effects, not elsewhere classified	0.003	0.997	0.000
G30.8 Other Alzheimer's disease	0.003	0.997	0.000
D03.9 Melanoma in situ, unspecified	0.000	0.997	0.003
I72.6 Aneurysm and dissection of vertebral artery	0.000	0.997	0.002
I72.4 Aneurysm of artery of lower extremity	0.000	0.997	0.003
I79 Disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.000	0.997	0.002
G31.2 Degeneration of nervous system due to alcohol	0.003	0.997	0.000
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.003	0.997	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.000	0.997	0.003
E72 Other disorders of amino-acid metabolism	0.000	0.997	0.002
C49.3 Connective and soft tissue of thorax	0.002	0.997	0.000
D03.7 Melanoma in situ of lower limb, including hip	0.000	0.997	0.002
S30.9 Superficial injury of abdomen, lower back and pelvis, part unspecified	0.000	0.997	0.002
I70.80 Atherosclerosis of other arteries (without gangrene)	0.000	0.997	0.002
H65.4 Other chronic nonsuppurative otitis media	0.000	0.997	0.002
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.002	0.998	0.000
C46 Kaposi's sarcoma	0.002	0.998	0.000
S30.0 Contusion of lower back and pelvis	0.000	0.998	0.002
I10-I15 Hypertensive diseases	0.000	0.998	0.002
C49.9 Connective and soft tissue, unspecified	0.002	0.998	0.000
E84 Cystic fibrosis	0.000	0.998	0.002
S30 Superficial injury of abdomen, lower back and pelvis	0.000	0.998	0.002
G30-G32 Other degenerative diseases of the nervous system	0.002	0.998	0.000
I70.00 Atherosclerosis of aorta (without gangrene)	0.000	0.998	0.002
D03.1 Melanoma in situ of eyelid, including canthus	0.000	0.998	0.002
E75.5 Other lipid storage disorders	0.000	0.998	0.002
E80.4 Gilbert's syndrome	0.000	0.998	0.002
I72.2 Aneurysm of renal artery	0.000	0.998	0.002
E80 Disorders of porphyrin and bilirubin metabolism	0.000	0.998	0.002
E77 Disorders of glycoprotein metabolism	0.000	0.998	0.002
E74 Other disorders of carbohydrate metabolism	0.000	0.998	0.002
E70 Disorders of aromatic amino-acid metabolism	0.000	0.998	0.002
C49.1 Connective and soft tissue of upper limb, including shoulder	0.002	0.998	0.000
C48.1 Specified parts of peritoneum	0.002	0.998	0.000
C49.0 Connective and soft tissue of head, face and neck	0.002	0.998	0.000
G31.1 Senile degeneration of brain, not elsewhere classified	0.002	0.998	0.000
S30.8 Other superficial injuries of abdomen, lower back and pelvis	0.000	0.998	0.002
E76 Disorders of glycosaminoglycan metabolism	0.000	0.998	0.002
E71 Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism	0.000	0.998	0.002
E90 Nutritional and metabolic disorders in diseases classified elsewhere	0.000	0.998	0.002
I70.81 Atherosclerosis of other arteries (with gangrene)	0.000	0.998	0.002
C49.2 Connective and soft tissue of lower limb, including hip	0.002	0.998	0.000
E75.2 Other sphingolipidosis	0.000	0.998	0.002
H65.3 Chronic mucoid otitis media	0.000	0.998	0.002
C49.6 Connective and soft tissue of trunk, unspecified	0.002	0.998	0.000
I72.9 Aneurysm of unspecified site	0.000	0.998	0.002
I70.01 Atherosclerosis of aorta (with gangrene)	0.000	0.998	0.002
T78.8 Other adverse effects, not elsewhere classified	0.002	0.998	0.000
S32.51 Fracture of pubis (open)	0.000	0.998	0.002
C49.8 Overlapping lesion of connective and soft tissue	0.002	0.998	0.000
C49.4 Connective and soft tissue of abdomen	0.002	0.998	0.000
T78.0 Anaphylactic shock due to adverse food reaction	0.002	0.998	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
H65 Nonsuppurative otitis media	0.000	0.998	0.002
E79 Disorders of purine and pyrimidine metabolism	0.000	0.998	0.002
I70.11 Atherosclerosis of renal artery (with gangrene)	0.000	0.998	0.002
I70.91 Generalized and unspecified atherosclerosis (with gangrene)	0.000	0.998	0.002
E75.6 Lipid storage disorder, unspecified	0.000	0.998	0.002
E75.4 Neuronal ceroid lipofuscinosis	0.000	0.998	0.002
E75.3 Sphingolipidosis, unspecified	0.000	0.998	0.002
E75.1 Other gangliosidosis	0.000	0.998	0.002
E75.0 GM2 gangliosidosis	0.000	0.998	0.002
S27.2 Traumatic heamopneumothorax	0.000	0.998	0.002
M47.86 Other spondylosis (Lumbar region)	0.002	0.998	0.000
E72.1 Disorders of sulphur-bearing amino-acid metabolism	0.000	0.998	0.002
J44.9 Chronic obstructive pulmonary disease, unspecified	0.002	0.998	0.000
T78.1 Other adverse food reactions, not elsewhere classified	0.002	0.998	0.000
I70.90 Generalized and unspecified atherosclerosis (without gangrene)	0.000	0.998	0.002
O68.0 Labour and delivery complicated by foetal heart rate anomaly	0.002	0.998	0.000
T78.9 Adverse effect, unspecified	0.002	0.998	0.000
I70.10 Atherosclerosis of renal artery (without gangrene)	0.000	0.998	0.002
E72.0 Disorders of amino-acid transport	0.000	0.998	0.002
I72.3 Aneurysm of iliac artery	0.000	0.998	0.002
Q23 Congenital malformations of aortic and mitral valves	0.002	0.998	0.000
I70.21 Atherosclerosis of arteries of extremities (with gangrene)	0.000	0.998	0.002
S52.60 Fracture of lower end of both ulna and radius (closed)	0.002	0.998	0.000
I79.1 Aortitis in diseases classified elsewhere	0.000	0.998	0.002
I79.0 Aneurysm of aorta in diseases classified elsewhere	0.000	0.998	0.002
C44.6 Skin of upper limb, including shoulder	0.000	0.998	0.002
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.002	0.998	0.000
C49.5 Connective and soft tissue of pelvis	0.002	0.998	0.000
C48.0 Retroperitoneum	0.002	0.998	0.000
B25.9 Cytomegaloviral disease, unspecified	0.000	0.998	0.002
G31.0 Circumscribed brain atrophy	0.002	0.998	0.000
N99.4 Postprocedural pelvic peritoneal adhesions	0.002	0.998	0.000
S30.2 Contusion of external genital organs	0.000	0.998	0.002
E72.9 Disorder of amino-acid metabolism, unspecified	0.000	0.998	0.002
E72.8 Other specified disorders of amino-acid metabolism	0.000	0.998	0.002
E72.5 Disorders of glycine metabolism	0.000	0.998	0.002
E72.4 Disorders of ornithine metabolism	0.000	0.998	0.002
E72.3 Disorders of lysine and hydroxylysine metabolism	0.000	0.998	0.002
E72.2 Disorders of urea cycle metabolism	0.000	0.998	0.002
E74.3 Other disorders of intestinal carbohydrate absorption	0.000	0.998	0.002
D00-D09 In situ neoplasms	0.000	0.998	0.002
E73 Lactose intolerance	0.000	0.998	0.002
I13 Hypertensive heart and renal disease	0.000	0.998	0.002
C47.1 Peripheral nerves of upper limb, including shoulder	0.002	0.998	0.000
S92 Fracture of foot, except ankle	0.000	0.998	0.002
C46.9 Kaposi's sarcoma, unspecified	0.002	0.998	0.000
C46.8 Kaposi's sarcoma of multiple organs	0.002	0.998	0.000
C46.7 Kaposi's sarcoma of other sites	0.002	0.998	0.000
C46.3 Kaposi's sarcoma of lymph nodes	0.002	0.998	0.000
C46.2 Kaposi's sarcoma of palate	0.002	0.998	0.000
C46.1 Kaposi's sarcoma of soft tissue	0.002	0.998	0.000
C46.0 Kaposi's sarcoma of skin	0.002	0.998	0.000
C47.9 Peripheral nerves and autonomic nervous system, unspecified	0.002	0.998	0.000
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system	0.002	0.998	0.000
C47.6 Peripheral nerves of trunk, unspecified	0.002	0.998	0.000
C47.5 Peripheral nerves of pelvis	0.002	0.998	0.000
C47.4 Peripheral nerves of abdomen	0.002	0.998	0.000
C47.3 Peripheral nerves of thorax	0.002	0.998	0.000
C47.2 Peripheral nerves of lower limb, including hip	0.002	0.998	0.000
C47.0 Peripheral nerves of head, face and neck	0.002	0.998	0.000
E70.3 Albinism	0.000	0.998	0.002
E77.8 Other disorders of glycoprotein metabolism	0.000	0.998	0.002
E84.9 Cystic fibrosis, unspecified	0.000	0.998	0.002
E84.0 Cystic fibrosis with pulmonary manifestations	0.000	0.998	0.002
I79.8 Other disorders of arteries, arterioles and capillaries in diseases classified elsewhere	0.000	0.998	0.002
I27 Other pulmonary heart diseases	0.002	0.998	0.000
S30.7 Multiple superficial injuries of abdomen, lower back and pelvis	0.000	0.998	0.002
E74.9 Disorder of carbohydrate metabolism, unspecified	0.000	0.998	0.002
E74.8 Other specified disorders of carbohydrate metabolism	0.000	0.998	0.002
E74.4 Disorders of pyruvate metabolism and gluconeogenesis	0.000	0.998	0.002
E74.2 Disorders of galactose metabolism	0.000	0.998	0.002
E74.1 Disorders of fructose metabolism	0.000	0.998	0.002
E77.9 Disorder of glycoprotein metabolism, unspecified	0.000	0.998	0.002
E77.1 Defects in glycoprotein degradation	0.000	0.998	0.002
E77.0 Defects in posttranslational modification of lysosomal enzymes	0.000	0.998	0.002
E84.8 Cystic fibrosis with other manifestations	0.000	0.998	0.002
E84.1 Cystic fibrosis with intestinal manifestations	0.000	0.998	0.002
G32 Other degenerative disorders of nervous system in diseases classified elsewhere	0.002	0.998	0.000
S32.10 Fracture of sacrum (closed)	0.000	0.998	0.002
D47.2 Monoclonal gammopathy	0.002	0.998	0.000
E70.9 Disorder of aromatic amino-acid metabolism, unspecified	0.000	0.998	0.002
E70.8 Other disorders of aromatic amino-acid metabolism	0.000	0.998	0.002
E70.2 Disorders of tyrosine metabolism	0.000	0.998	0.002
E70.1 Other hyperphenylalaninaemias	0.000	0.998	0.002
E70.0 Classical phenylketonuria	0.000	0.998	0.002
E80.5 Crigler-Najjar syndrome	0.000	0.998	0.002
E80.3 Defects of catalase and peroxydase	0.000	0.998	0.002
E80.1 Porphyria cutanea tarda	0.000	0.998	0.002
E80.0 Hereditary erythropoietic porphyria	0.000	0.998	0.002
I78.1 Naevus, nonneoplastic	0.000	0.998	0.002
S92.2 Fracture of other tarsal bone(s)	0.000	0.998	0.002
Y45.5 4-Aminophenol derivatives	0.002	0.998	0.000
S92.20 Fracture of other tarsal bone(s) (closed)	0.000	0.998	0.002
E71.3 Disorders of fatty-acid metabolism	0.000	0.998	0.002
E71.2 Disorder of branched-chain amino-acid metabolism, unspecified	0.000	0.998	0.002
E71.1 Other disorders of branched-chain amino-acid metabolism	0.000	0.998	0.002
E71.0 Maple-syrup-urine disease	0.000	0.998	0.002
E76.9 Disorder of glucosaminoglycan metabolism, unspecified	0.000	0.998	0.002
E76.8 Other disorders of glucosaminoglycan metabolism	0.000	0.998	0.002
E76.3 Mucopolysaccharidosis, unspecified	0.000	0.998	0.002
E76.2 Other mucopolysaccharidoses	0.000	0.998	0.002
E76.1 Mucopolysaccharidosis, type II	0.000	0.998	0.002
E76.0 Mucopolysaccharidosis, type I	0.000	0.998	0.002
Q21.1 Atrial septal defect	0.002	0.998	0.000
C48.2 Peritoneum, unspecified	0.002	0.998	0.000
D04 Carcinoma in situ of skin	0.000	0.998	0.002
E74.0 Glycogen storage disease	0.000	0.998	0.002
I27.8 Other specified pulmonary heart diseases	0.002	0.998	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.002	0.998	0.000
S32.1 Fracture of sacrum	0.000	0.998	0.002
D04.9 Skin, unspecified	0.000	0.998	0.002
D04.2 Skin of ear and external auricular canal	0.000	0.998	0.002
E80.7 Disorder of bilirubin metabolism, unspecified	0.000	0.998	0.002
H65.0 Acute serous otitis media	0.000	0.998	0.002
S32 Fracture of lumbar spine and pelvis	0.000	0.998	0.002
D47.1 Chronic myeloproliferative disease	0.002	0.998	0.000
E79.9 Disorder of purine and pyrimidine metabolism, unspecified	0.000	0.998	0.002
E79.8 Other disorders of purine and pyrimidine metabolism	0.000	0.998	0.002
E79.1 Lesch-Nyhan syndrome	0.000	0.998	0.002
Q23.0 Congenital stenosis of aortic valve	0.002	0.998	0.000
R19.0 Intra-abdominal and pelvic swelling, mass and lump	0.002	0.998	0.000
T78.4 Allergy, unspecified	0.002	0.998	0.000
S27.21 Traumatic haemopneumothorax (with open wound into thoracic cavity)	0.000	0.998	0.002
E80.2 Other porphyria	0.000	0.998	0.002
H65.1 Other acute nonsuppurative otitis media	0.000	0.998	0.002
I13.9 Hypertensive heart and renal disease, unspecified	0.000	0.998	0.002
K29.1 Other acute gastritis	0.002	0.998	0.000
S30.1 Contusion of abdominal wall	0.000	0.998	0.002
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.002	0.998	0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.000	0.998	0.002
D47.4 Osteomyelofibrosis	0.002	0.998	0.000
S92.1 Fracture of talus	0.000	0.998	0.002
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.000	0.998	0.002
H34.8 Other retinal vascular occlusions	0.000	0.998	0.002
Q23.9 Congenital malformation of aortic and mitral valves, unspecified	0.002	0.998	0.000
Q23.8 Other congenital malformations of aortic and mitral valves	0.002	0.998	0.000
Q23.4 Hypoplastic left heart syndrome	0.002	0.998	0.000
Q23.2 Congenital mitral stenosis	0.002	0.998	0.000
E21.2 Other hyperparathyroidism	0.000	0.998	0.002
G59.0 Diabetic mononeuropathy	0.002	0.998	0.000
I79.2 Peripheral angiopathy in diseases classified elsewhere	0.000	0.998	0.001
M89.55 Osteolysis (Pelvic region and thigh)	0.002	0.998	0.000
H02.6 Xanthelasma of eyelid	0.000	0.998	0.002
I11 Hypertensive heart disease	0.000	0.998	0.002
D04.5 Skin of trunk	0.000	0.998	0.002
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.002	0.998	0.000
E80.6 Other disorders of bilirubin metabolism	0.000	0.998	0.001
I13.1 Hypertensive heart and renal disease with renal failure	0.000	0.998	0.002
S32.8 Fracture of other and unspecified parts of lumbar spine and pelvis	0.000	0.998	0.002
S92.7 Multiple fractures of foot	0.000	0.998	0.002
D04.3 Skin of other and unspecified parts of face	0.000	0.998	0.002
D04.0 Skin of lip	0.000	0.998	0.002
E79.0 Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease	0.000	0.998	0.001
I13.0 Hypertensive heart and renal disease with (congestive) heart failure	0.000	0.998	0.002
E85 Amyloidosis	0.000	0.998	0.001
E73.8 Other lactose intolerance	0.000	0.998	0.001
E73.1 Secondary lactase deficiency	0.000	0.998	0.001
E73.0 Congenital lactase deficiency	0.000	0.998	0.001
H65.2 Chronic serous otitis media	0.000	0.998	0.002
Q23.3 Congenital mitral insufficiency	0.002	0.998	0.000
S52.6 Fracture of lower end of both ulna and radius	0.002	0.998	0.000
E88 Other metabolic disorders	0.000	0.998	0.002
Q21 Congenital malformations of cardiac septa	0.002	0.998	0.000
I27.1 Kyphoscoliotic heart disease	0.002	0.998	0.000
I77 Other disorders of arteries and arterioles	0.000	0.998	0.002
M86.97 Osteomyelitis, unspecified (Ankle and foot)	0.002	0.998	0.000
S92.10 Fracture of talus (closed)	0.000	0.998	0.002
F33.2 Recurrent depressive disorder, current episode severe without psychotic symptoms	0.002	0.998	0.000
G32.0 Subacute combined degeneration of spinal cord in diseases classified elsewhere	0.001	0.998	0.000
S32.80 Fracture of other and unspecified parts of lumbar spine and pelvis (closed)	0.000	0.998	0.002
S92.21 Fracture of other tarsal bone(s) (open)	0.000	0.998	0.001
G32.8 Other specified degenerative disorders of nervous system in diseases classified elsewhere	0.001	0.998	0.000
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.002	0.998	0.000
D00 Carcinoma in situ of oral cavity, oesophagus and stomach	0.000	0.998	0.002
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified	0.002	0.998	0.000
I13.2 Hypertensive heart and renal disease with both (congestive) heart failure and renal failure	0.000	0.998	0.001
I77.3 Arterial fibromuscular dysplasia	0.000	0.998	0.002
S92.9 Fracture of foot, unspecified	0.000	0.998	0.001
S92.4 Fracture of great toe	0.000	0.998	0.002
R25 Abnormal involuntary movements	0.001	0.998	0.001
D04.8 Skin of other sites	0.000	0.998	0.002
S32.11 Fracture of sacrum (open)	0.000	0.998	0.001
D01 Carcinoma in situ of other and unspecified digestive organs	0.000	0.998	0.002
D04.6 Skin of upper limb, including shoulder	0.000	0.998	0.002
Y45.4 Antirheumatics	0.002	0.998	0.000
Z91.1 Personal history of noncompliance with medical treatment and regimen	0.002	0.998	0.000
D02 Carcinoma in situ of middle ear and respiratory system	0.000	0.998	0.001
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.002	0.998	0.000
D68.2 Hereditary deficiency of other clotting factors	0.002	0.998	0.000
D69.9 Haemorrhagic condition, unspecified	0.002	0.998	0.000
H25.8 Other senile cataract	0.000	0.998	0.001
D09 Carcinoma in situ of other and unspecified sites	0.000	0.998	0.002
S52.61 Fracture of lower end of both ulna and radius (open)	0.002	0.998	0.000
S82.10 Fracture of upper end of tibia (closed)	0.000	0.998	0.002
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.001	0.998	0.000
S32.7 Multiple fractures of lumbar spine and pelvis	0.000	0.998	0.001
Y45.2 Propionic acid derivatives	0.002	0.998	0.000
M76.86 Other enthesopathies of lower limb, excluding foot (Lower leg)	0.000	0.998	0.002
D04.4 Skin of scalp and neck	0.000	0.998	0.001
E21.5 Disorder of parathyroid gland, unspecified	0.000	0.998	0.001
E21.4 Other specified disorders of parathyroid gland	0.000	0.998	0.001
E88.3 Tumour lysis syndrome	0.000	0.998	0.001
O35.8 Maternal care for other (suspected) foetal abnormality and damage	0.000	0.998	0.002
S52.70 Multiple fractures of forearm (closed)	0.002	0.998	0.000
S92.11 Fracture of talus (open)	0.000	0.998	0.001
S92.71 Multiple fractures of foot (open)	0.000	0.998	0.001
M89.5 Osteolysis	0.002	0.998	0.000
S32.3 Fracture of ilium	0.000	0.998	0.001
S32.2 Fracture of coccyx	0.000	0.998	0.001
Z53.2 Procedure not carried out because of patient's decision for other and unspecified reasons	0.002	0.998	0.000
I15 Secondary hypertension	0.000	0.998	0.001
N99.9 Postprocedural disorder of genito-urinary system, unspecified	0.001	0.998	0.000
N99.2 Postprocedural adhesions of vagina	0.001	0.998	0.000
Q21.3 Tetralogy of Fallot	0.001	0.998	0.000
S92.5 Fracture of other toe	0.000	0.998	0.001
S32.81 Fracture of other and unspecified parts of lumbar spine and pelvis (open)	0.000	0.998	0.001
S92.70 Multiple fractures of foot (closed)	0.000	0.998	0.001
I77.8 Other specified disorders of arteries and arterioles	0.000	0.998	0.001
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.001	0.998	0.000
Q20-Q28 Congenital malformations of the circulatory system	0.002	0.998	0.000
M89.97 Disorder of bone, unspecified (Ankle and foot)	0.002	0.998	0.000
D00.1 Oesophagus	0.000	0.998	0.001
D04.1 Skin of eyelid, including canthus	0.000	0.998	0.001
D09.9 Carcinoma in situ, unspecified	0.000	0.998	0.001
E85.2 Heredofamilial amyloidosis, unspecified	0.000	0.998	0.001
E85.1 Neuropathic heredofamilial amyloidosis	0.000	0.998	0.001
E85.0 Nonneuropathic heredofamilial amyloidosis	0.000	0.998	0.001
Q21.9 Congenital malformation of cardiac septum, unspecified	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations